We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

74 hedge funds and large institutions have $365M invested in ProQR Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

10% more funds holding

Funds holding: 67 → 74 (+7)

9% more capital invested

Capital invested by funds: $333M → $365M (+$31.4M)

8.76% more ownership

Funds ownership: 62.19% → 70.95% (+8.8%)

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

17% less call options, than puts

Call options by funds: $485K | Put options by funds: $584K

Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
25
Reduced
24
Closed
9
Calls
$485K
Puts
$584K
Net Calls
-$99K
Net Calls Change
-$925K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$9.89M
2
GPP
Great Point Partners
Connecticut
+$8.31M
3
RI
RTW Investments
New York
+$4.45M
4
Goldman Sachs
Goldman Sachs
New York
+$3.67M
5
BlackRock
BlackRock
New York
+$3.3M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.2M
2
KA
Kerrisdale Advisers
Florida
-$3.33M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.52M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.84M
5
DCM
DAFNA Capital Management
California
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mirae Asset Global Investments
26
Mirae Asset Global Investments
South Korea
$1.5M +$269K +35,261 +23%
Assenagon Asset Management
27
Assenagon Asset Management
Luxembourg
$1.43M -$307K -40,332 -18%
FSA
28
Franklin Street Advisors
North Carolina
$881K +$76.1K +10,000 +10%
JGC
29
J. Goldman & Co
New York
$818K -$719K -94,380 -48%
DCM
30
DAFNA Capital Management
California
$685K -$1.61M -210,907 -71%
UBS Group
31
UBS Group
Switzerland
$675K -$74.5K -9,789 -10%
AA
32
ALPS Advisors
Colorado
$660K +$627K +82,338 New
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$560K +$241K +31,614 +82%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$451K -$15.2K -2,000 -3%
Group One Trading
35
Group One Trading
Illinois
$401K +$375K +49,271 +5,929%
JF
36
Jump Financial
Illinois
$362K +$212K +27,900 +161%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$309K -$683K -89,657 -70%
Mitsubishi UFJ Asset Management
38
Mitsubishi UFJ Asset Management
Japan
$300K -$80.3K -10,542 -22%
Morgan Stanley
39
Morgan Stanley
New York
$293K -$567K -74,449 -67%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$290K – – –
CC
41
Corton Capital
Ontario, Canada
$280K +$266K +34,997 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$270K +$256K +33,682 New
AC
43
Apogem Capital
New York
$215K +$38.4K +5,045 +23%
Osaic Holdings
44
Osaic Holdings
Arizona
$170K +$1.52K +200 +0.9%
CBA
45
Coastal Bridge Advisors
Connecticut
$170K +$161K +21,200 New
Brown Advisory
46
Brown Advisory
Maryland
$151K +$144K +18,872 New
Jane Street
47
Jane Street
New York
$138K +$43.3K +5,692 +50%
Simplex Trading
48
Simplex Trading
Illinois
$130K +$124K +16,291 New
KA
49
Kerrisdale Advisers
Florida
$127K -$3.33M -437,286 -96%
Citigroup
50
Citigroup
New York
$127K -$102K -13,385 -46%
1
2
3 4

PRQR Hedge Fund Activity: Q4 2021 in Review

74 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2021, worth a combined $365M — up 9.4% from $333M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PRQR positions and 9 closed out — a net gain of 9 holders — while 25 added to existing stakes and 24 trimmed.

The largest buyer was Cowen and Company, adding an estimated $9.89M. The largest seller was Wellington Management Group, cutting an estimated $10.2M.

  • 74 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2021, up from 67 in Q3 2021.
  • Funds reported $365M of ProQR Therapeutics stock for Q4 2021, up 9.4% quarter-over-quarter.
  • 18 funds opened new ProQR Therapeutics positions in Q4 2021 and 9 closed out, a net change of +9 holders.
  • The largest ProQR Therapeutics buyer in Q4 2021 was Cowen and Company, an estimated $9.89M added.
  • The largest ProQR Therapeutics seller in Q4 2021 was Wellington Management Group, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2021.